Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
ABIP, acute, adjunctive, amikacin, amortizable, Amphotericin, analogue, Andersen, anemia, APBOpinion, API, apprised, ASPIRE, auction, aura, AZ, bacillary, bacteria, Baxter, belonged, belonging, Bio, BioMarin, bought, boxed, breakthrough, Buffalo, Byetta, capturing, cautionary, CBER, CDER, CEO, certolizumab, CF, chamber, Chicago, Cimzia, Cipro, Ciprofloxacin, classification, closest, clotting, competitor, concealed, concealment, concept, concurrently, conspiracy, constitute, constituted, cough, counterclaim, CRO, declaratory, detinue, discovered, Drapeau, driver, DuraSeal, eating, education, enrichment, Entrepreneurship, environment, erroneously, exploratory, fast, fatal, frame, fraudulent, FSP, fungal, Galway, glycosylation, Graduate, hand, HAP, hematologic, hemophilia, Hyderabad, hydrolyzable, ICU, Imaging, immunocompromised, immunosuppressed, Immunosuppression, impede, imposition, impracticable, inaccurate, indefinitely, indenture, India, intraveneously, Ireland, Irish, iv, joseph, kos, krivulka, landscape, lecturer, letter, lt, Mainfield, markup, Mateo, mild, Millenix, misrepresentation, ML, morbidity, mortality, mouth, narrowing, notwithstanding, oncology, OSI, Oxley, parenteral, pathogen, pegol, physician, pneumonia, polysialylation, pool, posaconazole, Prepaid, principle, punitive, questioning, rabbit, radiation, rare, ratio, rDNA, recall, refund, Regeneron, resignation, resigned, resigning, retrospective, revocation, revolutionize, rightfully, RSU, salary, Scottsdale, semiannually, shareholder, Squibb, Stanford, stem, sugar, super, suppressed, surfactant, tangible, taxation, terrorist, TGen, theAmerican, theory, thereon, treble, trust, UAH, underestimated, undergraduate, Union, unjust, unplanned, unwanted, vacate, VAP, ventilation, ventilator, Vfend, violation, warning, write, wrote
Removed:
absorbed, accrual, acetate, added, adherence, alc, alpha, amounting, anorexia, antibody, antitrypsin, attempting, autofiller, automatic, automation, bar, Battelle, bedtime, binding, biodegradable, breath, Bristol, cancer, capitalize, carefully, coating, construct, contrast, conventional, cooperation, creating, crititech, crystallization, custom, customized, DC, decided, dental, derive, developmental, diagnostically, discomfort, dispersible, dispersion, diverse, divert, dupont, Eli, emphysema, entail, Ethypharm, executed, extension, failed, Ferro, fragment, funded, generated, genetic, glycemic, goal, gynecological, hbalc, hydrogel, hydrolysable, identical, IIa, IIb, implementation, incorporate, infertility, influence, inhibit, inhibitor, injected, job, Lavipharm, leadership, leuprolide, lifetime, Lilly, macromolecule, marked, masking, McKinsey, MDI, mechanism, Medicare, Mehta, Memorial, mentioned, metering, microvascular, minimal, mission, mixture, modified, molecular, morphology, motion, myelosuppresive, nausea, neutral, Northwestern, NW, optimal, optimization, outer, outpatient, packaged, pain, parity, partial, patented, placement, postoperative, preference, pressure, proteinase, PulmoSphere, realize, recovered, refractory, regeneration, remained, replaced, reproducibly, reputation, request, requirement, SA, satisfaction, serum, shape, showed, significance, sized, soluble, stabilization, statistically, Straumann, structure, superior, supplemental, supplying, surface, surgery, systemically, taste, technically, temperature, tissue, tolerance, turn, ultrasound, validated, version, vessel, Virtually, vomiting, water, weight, wet, wide, women, workforce, ZS
Filing tables
Filing exhibits
- 10-K Annual report
- 10.19 Nektar Therapeutics' Restricted Stock Unit Notices and Agreement
- 10.28 Nektar Therapeutics 2000 Non-officer Equity Incentive Plan
- 10.46 Nektar Therapeutics' Severance Benefit Plan, As Amended
- 10.47 Summary of Variable Compensation Plan
- 21.1 Subsidiaries of Nektar Therapeutics
- 23.1 Consent of Ernst & Young LLP
- 31.1 Certification of Peo Required by Rule 13A-14(A) or Rule 15D-14(A)
- 31.2 Certification of Pfo Required by Rule 13A-14(A) or Rule 15D-14(A)
- 32.1 Section 1350 Certifications
Related press release
NKTR similar filings
Filing view
External links